CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 29 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,999 | -90.3% | 275,000 | +162.6% | 0.00% | -90.5% |
| Q2 2022 | $113,000 | -64.6% | 104,741 | 0.0% | 0.02% | -50.0% |
| Q1 2022 | $319,000 | -17.1% | 104,741 | +5.3% | 0.04% | -26.3% |
| Q4 2021 | $385,000 | -26.5% | 99,422 | 0.0% | 0.06% | +54.1% |
| Q3 2021 | $524,000 | -11.6% | 99,422 | -0.6% | 0.04% | -22.9% |
| Q2 2021 | $593,000 | -72.2% | 100,000 | -66.7% | 0.05% | -33.3% |
| Q1 2021 | $2,133,000 | -30.2% | 300,000 | -23.4% | 0.07% | -46.7% |
| Q4 2020 | $3,057,000 | – | 391,450 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 20,806 | $30,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |